Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Amazon Natural (AZNT) -- Ignore unavailable to you. Want to Upgrade?

To: marcos who wrote (1107)	8/23/1998 8:25:00 PM
From: jhild	Read Replies (2) \| Respond to of 26163

The log of the Edgar filings has a curious pattern here: A computer software failure made it impossible for the registrant to complete the report in a timely manner. (This is the ROUQUE C. PUCCI C.F.O. signed one.) www4.edgar-online.com A change in auditors resulted in new auditors not being engaged until February 13, 1998. Late engagement does not allow sufficient time for completion of audit before the March 15, 1998 due date. www4.edgar-online.com THE COMPANY IS AWAITING A DETERMINATION FROM THE SEC IN REGARDS TO TECHNOLOGY EVALUATION. THEREFORE, UNTIL SUCH TIME AS THE DETERMINATION IS MADE BY THE SEC, WE WILL NOT BE ABLE TO FINALIZE THE FINANCIAL STATEMENT. www4.edgar-online.com Still looking forward to The Indian ate my guava tree excuse.

To: marcos who wrote (1107)	8/23/1998 8:55:00 PM
From: Cavalry	Respond to of 26163

thank you for your post, i believe the fda hurdle has been bypassed since aznt products are considered food supplements however bmarts posts on this subject are more informed than mine, i agree the paper trail is important and i believe much of the confusion there lies with the cancellation of major portion of shares, if sec filing arrives quickly i believe many of your questions should be answered in retrospect while this investment looks most promising to me others indeed might choose to wait for updated financials, for me this is a risk/reward equation, the more people see in respect to financials the less risk but also the price could rise diminishing the reward as well. i too like oil and gas as i wrote last week on tim lukes thread when i mentioned another oil and gas company i like. good evening sir jesse

To: marcos who wrote (1107)	8/23/1998 9:46:00 PM
From: Hawkmoon	Read Replies (2) \| Respond to of 26163

Marcos, I agree with you. Aside from the administrative uncertainties involving the retiring of stock, I have no problem with the actual products. I would just like to see some assurance that the company does nothing that would create an FDA problem for them (and shareholders). I also would like to be reassured that when the common is retired and preferred issued that shareholders know what the converstion rate is for preferred to common and that insiders won't be instanting converting that preferred into common, subsequently selling that stock back into the market. If you retire 60+ million shares of common and issue 60+ million shares of easily convertible preferred stock, you really have gained nothing in the way of reducing O/S shares. Some assurance and disclosure by insiders would be welcome, as well legally binding documentation that would treat the preferred like 144 stock and restrict the amount of shares eligible for conversion based upon a percentage of volume. Doing such would greatly enhance my confidence that management is concerned with preserving shareholder value. Again, I have no problem with the products so long as advertising remains within FDA guidelines. And if there is a illegitimate short position out there, I congratulate the company's management for working towards eliminating this in shareholder's favor. If it succeeds, it certainly will warrant coverage far and wide in the financial journals, as well as sending a strong message to unscrupulous mmkrs who may be attempting to terminally short any stock. Regards, Ron